| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 21 | 2021 | 113 | 6.450 |
Why?
|
| Membrane Proteins | 16 | 2021 | 617 | 3.430 |
Why?
|
| Kidney Glomerulus | 9 | 2021 | 155 | 2.310 |
Why?
|
| Myosin Type I | 6 | 2021 | 20 | 2.290 |
Why?
|
| Glomerulonephritis | 3 | 2019 | 77 | 1.280 |
Why?
|
| Nephrotic Syndrome | 2 | 2019 | 61 | 1.280 |
Why?
|
| Zebrafish | 8 | 2020 | 187 | 1.260 |
Why?
|
| Kidney Diseases | 7 | 2019 | 307 | 1.200 |
Why?
|
| Signal Transduction | 17 | 2021 | 2689 | 1.130 |
Why?
|
| Zebrafish Proteins | 5 | 2020 | 100 | 1.090 |
Why?
|
| Cell Line | 16 | 2021 | 1752 | 1.070 |
Why?
|
| Doxorubicin | 5 | 2019 | 231 | 0.980 |
Why?
|
| Phosphorylation | 17 | 2021 | 1200 | 0.930 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2019 | 214 | 0.910 |
Why?
|
| Kidney | 4 | 2021 | 945 | 0.830 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2019 | 34 | 0.830 |
Why?
|
| Vesicular Transport Proteins | 3 | 2019 | 87 | 0.820 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 2 | 2019 | 27 | 0.810 |
Why?
|
| Transcriptome | 2 | 2020 | 164 | 0.780 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2017 | 25 | 0.780 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2019 | 43 | 0.770 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 63 | 0.760 |
Why?
|
| Protein Binding | 11 | 2021 | 1027 | 0.720 |
Why?
|
| Transforming Growth Factor beta | 3 | 2021 | 384 | 0.720 |
Why?
|
| Animals | 34 | 2021 | 20881 | 0.700 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 232 | 0.670 |
Why?
|
| Formoterol Fumarate | 1 | 2019 | 25 | 0.670 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 118 | 0.660 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.660 |
Why?
|
| Lipoproteins | 1 | 2020 | 161 | 0.650 |
Why?
|
| Glomerular Basement Membrane | 2 | 2019 | 10 | 0.640 |
Why?
|
| Drug Resistance | 1 | 2019 | 223 | 0.630 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.630 |
Why?
|
| Gene Deletion | 1 | 2019 | 235 | 0.620 |
Why?
|
| Mice | 20 | 2021 | 8474 | 0.610 |
Why?
|
| MAP Kinase Kinase Kinases | 6 | 2007 | 34 | 0.600 |
Why?
|
| Isodesmosine | 1 | 2017 | 6 | 0.600 |
Why?
|
| Cell Membrane | 6 | 2017 | 525 | 0.600 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 161 | 0.600 |
Why?
|
| Glucocorticoids | 1 | 2019 | 222 | 0.590 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 161 | 0.580 |
Why?
|
| Sphingolipids | 1 | 2020 | 337 | 0.560 |
Why?
|
| Glomerular Filtration Rate | 4 | 2021 | 274 | 0.530 |
Why?
|
| Ceramides | 1 | 2020 | 578 | 0.530 |
Why?
|
| Albuminuria | 3 | 2014 | 171 | 0.490 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.470 |
Why?
|
| Claudin-1 | 1 | 2013 | 3 | 0.460 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 81 | 0.450 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 47 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2003 | 82 | 0.450 |
Why?
|
| Streptokinase | 3 | 1998 | 23 | 0.440 |
Why?
|
| Actins | 5 | 2017 | 249 | 0.430 |
Why?
|
| Gene Knockdown Techniques | 5 | 2019 | 196 | 0.420 |
Why?
|
| Carrier Proteins | 4 | 2020 | 597 | 0.400 |
Why?
|
| src-Family Kinases | 3 | 2007 | 91 | 0.390 |
Why?
|
| Humans | 31 | 2021 | 68618 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2001 | 250 | 0.390 |
Why?
|
| Phosphoproteins | 2 | 2012 | 202 | 0.380 |
Why?
|
| Protein Transport | 5 | 2019 | 280 | 0.360 |
Why?
|
| Apoptosis | 5 | 2020 | 1641 | 0.340 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 56 | 0.340 |
Why?
|
| Binding Sites | 5 | 2016 | 631 | 0.320 |
Why?
|
| Renal Agents | 2 | 2019 | 8 | 0.320 |
Why?
|
| Mice, Knockout | 6 | 2019 | 1692 | 0.320 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2003 | 140 | 0.320 |
Why?
|
| Exocytosis | 2 | 2019 | 34 | 0.310 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 694 | 0.300 |
Why?
|
| Retina | 2 | 2021 | 252 | 0.290 |
Why?
|
| Puromycin Aminonucleoside | 2 | 2019 | 7 | 0.290 |
Why?
|
| Cilia | 2 | 2019 | 94 | 0.290 |
Why?
|
| Ischemia | 1 | 2008 | 229 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 615 | 0.280 |
Why?
|
| Plasminogen | 2 | 1997 | 28 | 0.280 |
Why?
|
| Eye Proteins | 2 | 2021 | 160 | 0.270 |
Why?
|
| Leucine Zippers | 3 | 2001 | 10 | 0.270 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.260 |
Why?
|
| Scattering, Small Angle | 2 | 2016 | 10 | 0.240 |
Why?
|
| Proteinuria | 2 | 2019 | 136 | 0.240 |
Why?
|
| Cell Movement | 3 | 2019 | 630 | 0.230 |
Why?
|
| Peptides | 3 | 2021 | 455 | 0.230 |
Why?
|
| Photoreceptor Cells | 2 | 2021 | 62 | 0.230 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1293 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-crk | 2 | 2014 | 3 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2673 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.210 |
Why?
|
| Enzyme Activation | 6 | 2003 | 791 | 0.200 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 562 | 0.200 |
Why?
|
| Intercellular Junctions | 1 | 2021 | 32 | 0.200 |
Why?
|
| Rats | 9 | 2019 | 5300 | 0.200 |
Why?
|
| Homozygote | 2 | 2019 | 119 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2019 | 191 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 2008 | 13 | 0.190 |
Why?
|
| Rhodopsin | 1 | 2021 | 135 | 0.180 |
Why?
|
| Fibrosis | 2 | 2019 | 371 | 0.180 |
Why?
|
| Mutation | 4 | 2019 | 1213 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2001 | 247 | 0.180 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 54 | 0.180 |
Why?
|
| Focal Adhesions | 1 | 2020 | 25 | 0.180 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 112 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 498 | 0.170 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1664 | 0.170 |
Why?
|
| Consanguinity | 1 | 2019 | 12 | 0.170 |
Why?
|
| Phenotype | 4 | 2021 | 947 | 0.170 |
Why?
|
| Eye | 1 | 2020 | 89 | 0.170 |
Why?
|
| Vitamin A | 1 | 2020 | 111 | 0.170 |
Why?
|
| Kidney Medulla | 1 | 2019 | 17 | 0.170 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 51 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.170 |
Why?
|
| Pedigree | 1 | 2019 | 159 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 127 | 0.170 |
Why?
|
| Gene Frequency | 1 | 2019 | 207 | 0.160 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 159 | 0.160 |
Why?
|
| Age of Onset | 1 | 2019 | 188 | 0.160 |
Why?
|
| Retinoids | 1 | 2020 | 122 | 0.160 |
Why?
|
| Plasma | 1 | 2019 | 58 | 0.160 |
Why?
|
| Disease Progression | 2 | 2019 | 1038 | 0.160 |
Why?
|
| Luciferases | 1 | 2019 | 105 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 46 | 0.160 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 186 | 0.160 |
Why?
|
| COS Cells | 6 | 2007 | 155 | 0.160 |
Why?
|
| Exosomes | 1 | 2019 | 44 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2019 | 80 | 0.160 |
Why?
|
| Liver | 2 | 2021 | 1118 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.160 |
Why?
|
| Homeostasis | 1 | 2020 | 291 | 0.160 |
Why?
|
| Cysts | 1 | 2019 | 70 | 0.160 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 19 | 0.160 |
Why?
|
| ROC Curve | 1 | 2019 | 392 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 301 | 0.150 |
Why?
|
| Lipid Droplets | 1 | 2017 | 4 | 0.150 |
Why?
|
| Protein Domains | 1 | 2017 | 74 | 0.150 |
Why?
|
| Dimerization | 3 | 2003 | 99 | 0.150 |
Why?
|
| Protective Agents | 1 | 2017 | 36 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 49 | 0.150 |
Why?
|
| Male | 9 | 2019 | 37321 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 48 | 0.150 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 78 | 0.140 |
Why?
|
| Cell Survival | 1 | 2020 | 901 | 0.140 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2017 | 12 | 0.140 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2017 | 46 | 0.140 |
Why?
|
| Models, Molecular | 2 | 2016 | 546 | 0.140 |
Why?
|
| Benzazepines | 1 | 2017 | 104 | 0.140 |
Why?
|
| Membrane Microdomains | 2 | 2014 | 32 | 0.140 |
Why?
|
| Indoles | 1 | 2017 | 146 | 0.140 |
Why?
|
| Drug Discovery | 1 | 2017 | 94 | 0.140 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 53 | 0.130 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.130 |
Why?
|
| Morphogenesis | 2 | 2014 | 159 | 0.130 |
Why?
|
| Point Mutation | 1 | 2016 | 97 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 710 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 365 | 0.130 |
Why?
|
| Species Specificity | 1 | 2016 | 303 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1140 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 328 | 0.130 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 1083 | 0.130 |
Why?
|
| Transfection | 4 | 2014 | 782 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2012 | 376 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 2083 | 0.130 |
Why?
|
| Peptide Mapping | 3 | 2003 | 39 | 0.130 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2014 | 14 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 261 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 46 | 0.120 |
Why?
|
| Female | 8 | 2019 | 38074 | 0.120 |
Why?
|
| Genotype | 2 | 2014 | 786 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2019 | 447 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 77 | 0.110 |
Why?
|
| Glomerular Filtration Barrier | 1 | 2013 | 3 | 0.110 |
Why?
|
| Morpholinos | 1 | 2013 | 8 | 0.110 |
Why?
|
| Permeability | 1 | 2013 | 131 | 0.110 |
Why?
|
| HIV-1 | 1 | 2014 | 177 | 0.110 |
Why?
|
| Edema | 1 | 2013 | 66 | 0.110 |
Why?
|
| Molecular Motor Proteins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 32 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3259 | 0.110 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2012 | 14 | 0.110 |
Why?
|
| Okadaic Acid | 2 | 2003 | 22 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2012 | 19 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2003 | 33 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 786 | 0.100 |
Why?
|
| Child, Preschool | 1 | 2019 | 3187 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1447 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 271 | 0.100 |
Why?
|
| PDZ Domains | 1 | 2012 | 5 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2012 | 44 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2012 | 94 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 742 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2012 | 97 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 164 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 136 | 0.100 |
Why?
|
| Gelsolin | 1 | 2011 | 6 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2011 | 25 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 839 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 351 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 239 | 0.090 |
Why?
|
| Adolescent | 3 | 2019 | 8912 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2012 | 397 | 0.090 |
Why?
|
| Child | 2 | 2019 | 6405 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2011 | 131 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2012 | 384 | 0.090 |
Why?
|
| Neurons | 2 | 2007 | 881 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 300 | 0.080 |
Why?
|
| Amidohydrolases | 2 | 1998 | 60 | 0.070 |
Why?
|
| Actin Cytoskeleton | 2 | 2017 | 37 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 929 | 0.070 |
Why?
|
| Catalysis | 1 | 2007 | 123 | 0.070 |
Why?
|
| Trypsin | 2 | 1997 | 64 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 4 | 2011 | 322 | 0.070 |
Why?
|
| Amino Acids | 1 | 2007 | 131 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 35 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 39 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2005 | 41 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 1997 | 483 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2011 | 420 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 411 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 18 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1173 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 48 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 1 | 2003 | 31 | 0.060 |
Why?
|
| Threonine | 1 | 2003 | 47 | 0.060 |
Why?
|
| Pseudopodia | 2 | 2014 | 16 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 272 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 152 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2001 | 195 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 492 | 0.050 |
Why?
|
| Dyneins | 1 | 2021 | 10 | 0.050 |
Why?
|
| Electroretinography | 1 | 2021 | 122 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 226 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2021 | 53 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2017 | 954 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 88 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 314 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| Urine | 1 | 2019 | 47 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2019 | 251 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 204 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 47 | 0.040 |
Why?
|
| Protein Kinases | 1 | 1999 | 122 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 659 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1998 | 122 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 490 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 57 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 5717 | 0.040 |
Why?
|
| Blastomeres | 1 | 2017 | 1 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 700 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2001 | 753 | 0.040 |
Why?
|
| Microtubules | 1 | 2017 | 104 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 64 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 34 | 0.040 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2017 | 25 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 134 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 236 | 0.040 |
Why?
|
| Pyrroles | 1 | 2017 | 83 | 0.040 |
Why?
|
| Kinetics | 1 | 1998 | 1047 | 0.030 |
Why?
|
| Cell Division | 1 | 2017 | 541 | 0.030 |
Why?
|
| Cattle | 1 | 1997 | 475 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1995 | 165 | 0.030 |
Why?
|
| Papain | 1 | 2014 | 6 | 0.030 |
Why?
|
| Nephrosis, Lipoid | 1 | 2014 | 9 | 0.030 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2014 | 8 | 0.030 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2014 | 12 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2014 | 48 | 0.030 |
Why?
|
| Protamines | 1 | 2014 | 14 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 97 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 243 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2014 | 362 | 0.030 |
Why?
|
| Brefeldin A | 1 | 2012 | 11 | 0.030 |
Why?
|
| Secretory Pathway | 1 | 2012 | 6 | 0.030 |
Why?
|
| Chloroquine | 1 | 2012 | 21 | 0.030 |
Why?
|
| Hydrazones | 1 | 2012 | 11 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 32 | 0.030 |
Why?
|
| India | 1 | 2012 | 41 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 266 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2014 | 326 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 45 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2012 | 20 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2012 | 23 | 0.030 |
Why?
|
| Larva | 1 | 2012 | 39 | 0.030 |
Why?
|
| Antimalarials | 1 | 2012 | 71 | 0.030 |
Why?
|
| Heterozygote | 1 | 2012 | 174 | 0.030 |
Why?
|
| Transgenes | 1 | 2012 | 92 | 0.030 |
Why?
|
| Endocytosis | 1 | 2012 | 113 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2012 | 59 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 77 | 0.030 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 2012 | 4 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2012 | 27 | 0.030 |
Why?
|
| Quinazolines | 1 | 2012 | 70 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 79 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 386 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 511 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 80 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 197 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 175 | 0.020 |
Why?
|
| Middle Aged | 3 | 2014 | 21147 | 0.020 |
Why?
|
| Adult | 3 | 2014 | 21403 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 223 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 190 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 770 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 618 | 0.020 |
Why?
|
| Rural Population | 1 | 2012 | 398 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 1593 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1174 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2007 | 13 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2007 | 41 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 65 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 3705 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 14862 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2005 | 10 | 0.020 |
Why?
|
| Calcineurin | 1 | 2005 | 13 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2005 | 200 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 87 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Glucose | 1 | 2005 | 307 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2003 | 2 | 0.010 |
Why?
|
| Octoxynol | 1 | 2003 | 19 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 4848 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 34 | 0.010 |
Why?
|
| Detergents | 1 | 2003 | 34 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1174 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 234 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5731 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 155 | 0.010 |
Why?
|
| Insulin | 1 | 2005 | 619 | 0.010 |
Why?
|
| Tyrosine | 1 | 2003 | 196 | 0.010 |
Why?
|
| PAX2 Transcription Factor | 1 | 2001 | 11 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2001 | 57 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 509 | 0.010 |
Why?
|